View of Guidelines for the management of adverse events following CD19 CAR-T cell therapy in adult patients with lymphomas and acute lymphoblastic leukemia: consensus of expert panel from certified centers in Czechia and Slovakia for 2025

Return to Issue Details Guidelines for the management of adverse events following CD19 CAR-T cell therapy in adult patients with lymphomas and acute lymphoblastic leukemia: consensus of expert panel from certified centers in Czechia and Slovakia for 2025 Download Download PDF